Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05067595 · ClinicalTrials.gov registry record · Phase 1
Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease
A Phase 1 study of Intestinal Graft Versus Host Disease, sponsored by Fred Hutchinson Cancer Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT05067595 is a Phase 1 study of Intestinal Graft Versus Host Disease that is actively recruiting participants, run by Fred Hutchinson Cancer Center. The registered enrollment target is 72 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05067595, a Phase 1 study of Intestinal Graft Versus Host Disease, is actively recruiting participants, sponsored by Fred Hutchinson Cancer Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase I trial studies how well fecal microbiota transplant and dietary fiber supplementation work in treating patients with gut graft versus host disease. Fecal microbiota transplant entails inoculating donor stool into a recipient's gastrointestinal tract. Changing the gut microbiome by fecal microbiota transplant and fiber supplementation may help treat gut graft versus host disease.
Conditions Studied
Interventions
- PROCEDURE Colonoscopy
- OTHER Survey Administration
- BIOLOGICAL Fecal Microbiota Transplantation
- DIETARY_SUPPLEMENT Nutritional Supplementation
Study Locations (1)
Washington
- Fred Hutch/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2025-01-24 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05067595
The ClinicalTrials.gov registry entry for NCT05067595 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intestinal Graft Versus Host Disease appearing as the primary indexed condition, and to 4 interventions - of which Colonoscopy is the first listed.
NCT05067595 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT05067595 about?
NCT05067595 is a clinical study titled "Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease". This phase I trial studies how well fecal microbiota transplant and dietary fiber supplementation work in treating patients with gut graft versus host disease. Fecal microbiota transplant entails inoculating donor stool into a recipient's gastrointestinal tract. Changing the gut microbiome by fecal ...
What is the current status of trial NCT05067595?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2025-01-24. Estimated completion is 2027-12-31.
What conditions does trial NCT05067595 study?
This clinical trial studies the following conditions: Intestinal Graft Versus Host Disease.
What interventions are being tested in trial NCT05067595?
The interventions under investigation include: Colonoscopy (PROCEDURE), Survey Administration (OTHER), Fecal Microbiota Transplantation (BIOLOGICAL), Nutritional Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05067595?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05067595 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.